We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRX
2701
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $96.4K | ﹤0.01% |
10,330
| – | – |
|
|
PHLT
2702
DELISTED
Performant Healthcare Inc
PHLT
| $96.3K | ﹤0.01% |
+35,666
| New | +$103K |
|
2703
Codexis
CDXS
$176M
| $96.3K | ﹤0.01% |
34,375
+10,708
| +45% | +$34.6K |
|
|
HRT
2704
DELISTED
HireRight Holdings Corporation
HRT
| $96.2K | ﹤0.01% |
8,503
-6,930
| -45% | -$72.7K |
|
2705
Rallybio
RLYB
$90.9M
| $96.1K | ﹤0.01% |
+2,122
| New | +$104K |
|
2706
Quantum-Si Incorporated
QSI
$191M
| $96.1K | ﹤0.01% |
53,683
| – | – |
|
2707
Ponce Financial Group
PDLB
$502M
| $96.1K | ﹤0.01% |
+11,054
| New | +$86.3K |
|
|
PAMT
2708
PAMT Corp
PAMT
$283M
| $95.8K | ﹤0.01% |
3,579
| – | – |
|
|
CMBM
2709
DELISTED
Cambium Networks
CMBM
| $95.6K | ﹤0.01% |
6,280
| – | – |
|
|
PPLI
2710
People Inc
PPLI
$3B
| $95.6K | ﹤0.01% |
1,855
-84
| -4% | -$3.85K |
|
2711
C&F Financial
CFFI
$284M
| $95.3K | ﹤0.01% |
+1,775
| New | +$94K |
|
2712
Ring Energy
REI
$352M
| $94.3K | ﹤0.01% |
55,160
+6,991
| +15% | +$12.8K |
|
2713
Zevra Therapeutics
ZVRA
$670M
| $94.2K | ﹤0.01% |
+18,464
| New | +$99.5K |
|
2714
CorMedix
CRMD
$648M
| $94K | ﹤0.01% |
+23,705
| New | +$117K |
|
2715
Core Molding Technologies
CMT
$228M
| $94K | ﹤0.01% |
+4,130
| New | +$80.2K |
|
2716
Freshpet
FRPT
$3.47B
| $93.8K | ﹤0.01% |
1,426
-528
| -27% | -$34.6K |
|
2717
Latham Group
SWIM
$912M
| $93.5K | ﹤0.01% |
25,195
| – | – |
|
2718
Huntsman Corp
HUN
$1.81B
| $93.4K | ﹤0.01% |
3,458
-317
| -8% | -$8.23K |
|
2719
InfuSystem Holdings
INFU
$249M
| $93.2K | ﹤0.01% |
+9,683
| New | +$87.7K |
|
2720
Southern First Bancshares
SFST
$613M
| $93.1K | ﹤0.01% |
3,760
| – | – |
|
|
VOXX
2721
DELISTED
VOXX International Corporation Class A
VOXX
| $92.9K | ﹤0.01% |
+7,444
| New | +$88.1K |
|
2722
Altimmune
ALT
$558M
| $92.9K | ﹤0.01% |
+26,315
| New | +$118K |
|
|
PWOD
2723
DELISTED
Penns Woods Bancorp
PWOD
| $92.7K | ﹤0.01% |
+3,703
| New | +$89.8K |
|
2724
ARS Pharmaceuticals
SPRY
$589M
| $92.4K | ﹤0.01% |
+13,784
| New | +$92K |
|
2725
AlTi Global
ALTI
$456M
| $91.9K | ﹤0.01% |
+11,993
| New | +$84K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
EIM
OSAM
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.